home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Adverse Effects on Skin–How to Formulate a Safer Topically Applied Product

  March 20, 2012  
CfPA - The Center for Professional Advancement, New Brunswick, NJ
July 25, 2012

ho Should Attend
This course will be valuable to professionals employed in the Pharmaceutical, Cosmetic and Personal Care industry especially those involved in topically applied product development. In addition, individuals working in the following areas will benefit from this intensive one-day course:

  • Dermatology community and related industries
  • Professionals in hospitals that work on topical chemicals
  • Professionals in regulatory institutions that work on dermal

The Pharmaceutical and Cosmetic and Personal Care industry both face challenges of developing topically applied formulations that present no adverse reactions when applied to skin. This one day course is designed to explain the different reactions possible, their cause, biochemistry and prevention.

SAVE $300!
Take this course and its Companion Course:
Claim Substantiation for Clinical Studies of Cosmetic Products 
July 23-24, 2012, ID# 2398, Offering# 1207-402 and save $300 off the combined Regular Registration tuition

Organized by: CfPA - The Center for Professional Advancement
Invited Speakers: Nava Dayan, Ph.D.; Skin Care Research Expert

Dr. Nava Dayan earned her Ph.D. in Pharmaceutics from the Hebrew University in Jerusalem specializing in skin delivery. She is currently an Associate Adjunct Professor in the Ernest Mario School of Pharmacy at Rutgers University, and the Research and Development and Safety Assessment Director at Lipo Chemicals Inc. During her 24 years of experience she has specialized in a variety of areas related to skin treatment:

  • The research and understanding of the interaction between topically applied compounds
    and the skin
  • Findings in skin biochemistry and especially the upper layer of the skin- the stratum 
  • Delivery of active compounds into and through the skin and the development of delivery 
    systems to facilitate transport, improve bio-availability and reduce toxicity
  • Design and development of topically applied formulations
  • Design of clinical studies to substantiate market claims and to assure safety
  • Academic teaching and lecturing
  • Industrial experience in both development of active compounds, delivery systems and 
    finished formulations
  • Skin absorption studies in vivo and in vitro for safety/ efficacy assessment
  • In vitro methodologies for safety assessment of topically applied compounds

Dr. Dayan has received numerous awards of excellence for various papers she has authored. A technology developed by Dr. Dayan is the recipient of the Gold Award for Innovation at the 2011 In Cosmetics European Show. She is the author and co-author more than 150 publications including book chapters and was granted 8 patents. She is also the editor of the “Skin Aging Hand Book” published by Elsevier; “Innate Immunity of Skin and Oral Mucosa” Book co-edited with Prof. Philip Wertz, “Formulating Skin Care with Natural Products” Book co-edited with Dr. Lambros Kromidas; both published by Wiley and sons. Dr. Dayan is a member of the Dermatopharmaceutics Focus Group, and the Abstract Review Committee for the American Association of Pharmaceutical Scientists (AAPS). She is serves as the Educational Chair of the NYSCC Chapter and on the Scientific Advisory Board of Health Beauty America Expo and the Center for Dermal Research at the Center for Biomaterials. Dr. Dayan teaches at Rutgers University and is the Director of a variety of courses at the Center for Professional Advancement.
Deadline for Abstracts: n/a
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.